Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations.

Several human skin models employing primary cells and immortalized cell lines used as monocultures or combined to produce reconstituted 3D skin constructs have been developed. Furthermore, these models have been included in European genotoxicity and sensitization/irritation assay validation projects. In order to help interpret data, Cosmetics Europe (formerly COLIPA) facilitated research projects that measured a variety of defined phase I and II enzyme activities and created a complete proteomic profile of xenobiotic metabolizing enzymes (XMEs) in native human skin and compared them with data obtained from a number of in vitro models of human skin. Here, we have summarized our findings on the current knowledge of the metabolic capacity of native human skin and in vitro models and made an overall assessment of the metabolic capacity from gene expression, proteomic expression, and substrate metabolism data. The known low expression and function of phase I enzymes in native whole skin were reflected in the in vitro models. Some XMEs in whole skin were not detected in in vitro models and vice versa, and some major hepatic XMEs such as cytochrome P450-monooxygenases were absent or measured only at very low levels in the skin. Conversely, despite varying mRNA and protein levels of phase II enzymes, functional activity of glutathione S-transferases, N-acetyltransferase 1, and UDP-glucuronosyltransferases were all readily measurable in whole skin and in vitro skin models at activity levels similar to those measured in the liver. These projects have enabled a better understanding of the contribution of XMEs to toxicity endpoints.

[1]  M. Amelia,et al.  Photophysical Properties and Photobiological Behavior of Amodiaquine, Primaquine and Chloroquine , 2007, Photochemistry and photobiology.

[2]  H. Merk,et al.  Cytochrome P450-mediated activation of the fragrance compound geraniol forms potent contact allergens. , 2008, Toxicology and applied pharmacology.

[3]  Jean Krutmann,et al.  Role of HuR and p38MAPK in Ultraviolet B-induced Post-transcriptional Regulation of COX-2 Expression in the Human Keratinocyte Cell Line HaCaT* , 2009, The Journal of Biological Chemistry.

[4]  A. Berghard,et al.  Serum and extracellular calcium modulate induction of cytochrome P-450IA1 in human keratinocytes. , 1990, The Journal of biological chemistry.

[5]  R. E. Stevenson,et al.  Establishment of a strain of human skin cells on chemically defined medium NCTC 109. , 1961, American journal of hygiene.

[6]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[7]  A. Schnuch,et al.  Genetic factors in contact allergy—review and future goals , 2011, Contact dermatitis.

[8]  F. Gonzalez,et al.  Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. , 1994, Drug metabolism reviews.

[9]  Mitchell Klausner,et al.  Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay. , 2009, Mutation research.

[10]  W. Lu,et al.  Effect of PCB153 on BaP-induced genotoxicity in HepG2 cells via modulation of metabolic enzymes. , 2009, Mutation research.

[11]  Jun Yao,et al.  Cyclooxygenase-2 expression during immortalization and breast cancer progression. , 2008, Cancer research.

[12]  P. G. Wells,et al.  Peroxidase-dependent bioactivation and oxidation of DNA and protein in benzo[a]pyrene-initiated micronucleus formation. , 1997, Free radical biology & medicine.

[13]  S. Krishnan,et al.  Electrochemiluminescent arrays for cytochrome P450-activated genotoxicity screening. DNA damage from benzo[a]pyrene metabolites. , 2007, Analytical chemistry.

[14]  A. Parodi,et al.  A comparative study of leukaemia inhibitory factor and interleukin-1alpha intracellular content in a human keratinocyte cell line after exposure to cosmetic fragrances and sodium dodecyl sulphate. , 2010, Toxicology letters.

[15]  C. Vogel.  Prostaglandin H synthases and their importance in chemical toxicity. , 2000, Current drug metabolism.

[16]  Nicola J Hewitt,et al.  A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation. , 2009, Regulatory toxicology and pharmacology : RTP.

[17]  C. Falany,et al.  Human cytosolic sulfotransferase 2B1: Isoform expression, tissue specificity and subcellular localization , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  D. Lewis,et al.  Up-regulation of CYP1A/B in rat lung and liver, and human liver precision-cut slices by a series of polycyclic aromatic hydrocarbons; association with the Ah locus and importance of molecular size. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[19]  M. Aardema,et al.  Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. , 2009, Mutation research.

[20]  Nicola J Hewitt,et al.  International prevalidation studies of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay: transferability and reproducibility. , 2010, Mutation research.

[21]  Jean Krutmann,et al.  Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I): Phase I xenobiotic metabolism in human skin and in vitro skin models , 2012 .

[22]  B. De Wever,et al.  Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles , 1999, Cell Biology and Toxicology.

[23]  H. Merk,et al.  Cutaneous metabolic activation of carvoxime, a self-activating, skin-sensitizing prohapten. , 2009, Chemical research in toxicology.

[24]  R. Edwards,et al.  Elucidation of Xenobiotic Metabolism Pathways in Human Skin and Human Skin Models by Proteomic Profiling , 2012, PloS one.

[25]  R L Binder,et al.  Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[26]  Jean Krutmann,et al.  Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte‐based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I) , 2012, Experimental dermatology.

[27]  M. Ingelman-Sundberg,et al.  Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[28]  M. T. Donato,et al.  Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[29]  S. Penco,et al.  Induction by xenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[30]  Fernand Labrie,et al.  Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin™ and full thickness model from Episkin™ , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  N. Hewitt,et al.  Effects of the genotoxic compounds, benzo[a]pyrene and cyclophosphamide on phase 1 and 2 activities in EpiDerm™ models , 2012, Xenobiotica; the fate of foreign compounds in biological systems.

[32]  Jean Krutmann,et al.  Xenobiotic metabolism capacities of human skin in comparison with a 3D‐epidermis model and keratinocyte‐based cell culture as in vitro alternatives for chemical testing: phase II enzymes , 2012, Experimental dermatology.

[33]  U. Yasar,et al.  Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation , 2003, The Pharmacogenomics Journal.

[34]  R. Edwards,et al.  Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[35]  H. Yamazaki,et al.  Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[36]  A. Melchini,et al.  Exposure of human skin to benzo[a]pyrene: role of CYP1A1 and aryl hydrocarbon receptor in oxidative stress generation. , 2010, Toxicology.

[37]  G. Nohynek,et al.  Under the skin: Biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. , 2005, Toxicology letters.

[38]  Robert Landsiedel,et al.  Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig , 2007, Drug metabolism reviews.

[39]  T. Boyer,et al.  Characterization of glutathione S-transferase in cultured human keratinocytes. , 1991, The Journal of investigative dermatology.

[40]  T. Iyanagi,et al.  Glucuronidation of carcinogen metabolites by complementary DNA-expressed uridine 5'-diphosphate glucuronosyltransferases. , 1993, Cancer research.

[41]  M. Aardema,et al.  Evaluation of chemicals requiring metabolic activation in the EpiDerm™ 3D human reconstructed skin micronucleus (RSMN) assay. , 2013, Mutation research.

[42]  Yuko Higashi,et al.  Expression of cholesterol sulfotransferase (SULT2B1b) in human skin and primary cultures of human epidermal keratinocytes. , 2004, The Journal of investigative dermatology.

[43]  C L Galli,et al.  Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[44]  S. Hecht,et al.  Preferential Glutathione Conjugation of a Reverse Diol Epoxide Compared with a Bay Region Diol Epoxide of Benzo[a]pyrene in Human Hepatocytes , 2010, Drug Metabolism and Disposition.

[45]  R. Weaver,et al.  Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. , 1994, Biochemical pharmacology.

[46]  N. Ledirac,et al.  Comparative study of CYP1A1 induction by 3-methylcholanthrene in various human hepatic and epidermal cell types. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.